Title : Words of wisdom. Re: Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. Attard G, Reid AH, Yap TA, et al. J Clin Oncol 2008;26:4563-71.

Pub. Date : 2009 Jul

PMID : 19995520






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Re: Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens